Moreover, the choice of adding the TLR2 contribution to the proliferation pathway derives from the observation that the TLR2 receptor shares the PI3K activation network [13] with ErbB2 [14], and accounts for recent results that show TLR2 to be expressed by breast cancer cell lines [15] and to be involved in cancer invasiveness. Here, TLR2 is linked to breast carcinoma.